Brief: Orthofix Reports Fourth Quarter And Full Year 2023 Results

Orthofix Medical

05/03/2024 21:34

March 5 (Reuters) - Orthofix Medical Inc  OFIX.O :
    * ORTHOFIX REPORTS FOURTH QUARTER AND FULL YEAR 2023 RESULTS
    * SEES FY NET SALES TO RANGE BETWEEN $785 MILLION TO $795
MILLION
    * SEES FY NON-GAAP ADJUSTED EBITDA OF $62 MILLION TO $67
MILLION
    * SEES TO EXIT Q4 2024 FREE CASH FLOW POSITIVE
    * Q4 NET SALES WERE $200.4 MILLION, AN INCREASE OF 64% ON A
REPORTED BASIS
    * QTRLY LOSS PER SHARE $0.59
    * Q4 EARNINGS PER SHARE VIEW $-0.08, REVENUE VIEW $195.3
MILLION
-- LSEG IBES DATA
    * FY2024 EARNINGS PER SHARE VIEW $-0.11, REVENUE VIEW $798.6
MILLION -- LSEG IBES DATA

Source text for Eikon:  ID:nBw2QGxcka 
Further company coverage:  OFIX.O